The role of depression in obesity and the relationship between cognitive functions, leptin, ghrelin, and neuropeptide Y

Purpose: It is known that there is a two-way relationship in the etiopathogenesis of depression and obesity. This study aimed to investigate serum ghrelin, leptin, neuropeptide Y levels, cognitive functions, and atypical depressive features in obese and depressed patients. It is expected that obese and depressed patients will show similar features in terms of biochemical parameters and cognitive functions, and atypical depressive features may be high in obese individuals. Materials and methods: The study included 56 obese individuals, 60 patients with major depressive disorder (MDD), and 53 healthy controls (HC). The questionnaires administered included socio-demographic data form, Hamilton Depression Rating Scale, Hamilton Anxiety Scale, Dutch Eating Behaviour Questionnaire, Structured Interview Guide for the Hamilton Depression Rating Scale-Seasonal Affective Disorder Version (SIGH-SAD). Cognitive functions were assessed with short computer version of Wisconsin Card Sorting Test (WCST), Berg’s WCST, Stroop Colour-Word Test-Victoria version. Serum ghrelin, leptin, and neuropeptide Y levels were measured. Results: The depression scores were found higher MDD group than obesity and HC groups (p<0.001) and anxiety scores similar in MDD and obesity groups (p=0.064). The groups had similar mean SIGH-SAD scores (p=0.989). There was no difference between groups in WCST scores (p>0.05). Differences were detected between the groups in the Stroop test. Leptin levels were higher (p<0.001), ghrelin (p=0.038) and neuropeptide Y (p<0.001) levels lower in obesity group compared to MDD and HC. Ghrelin levels negatively correlated with total number of incorrect responses in terms of cognitive functions in obese individuals (r=-0.259 p=0.049). Conclusion: In our study, it was determined that although depressive symptoms were high in obesity, there were no atypical depressive features, executive functions were similar between the groups, and neurochemical marker levels were not similar in obesity and depression. Our results do not support the relationship between obesity and atypical depression.

Authors

Institutions

Publication Details

Journal
Pamukkale Medical Journal
Published
2025-04-29
DOI
https://doi.org/10.31362/patd.1570780
Primary Topic
Regulation of Appetite and Obesity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The role of depression in obesity and the relationship between cognitive functions, leptin, ghrelin, and neuropeptide Y

Tuğçe Toker Uğurlu, Osman Zülkif Topak, Muhammet Gündüz, Özge Karaca et al.
Pamukkale Medical Journal
Regulation of Appetite and Obesity
article

The role of depression in obesity and the relationship between cognitive functions, leptin, ghrelin, and neuropeptide Y

Tuğçe Toker Uğurlu, Osman Zülkif Topak, Muhammet Gündüz, Özge Karaca, Yaşar Enli, Gülfizar Sözeri Varma
article en

Abstract

Purpose: It is known that there is a two-way relationship in the etiopathogenesis of depression and obesity. This study aimed to investigate serum ghrelin, leptin, neuropeptide Y levels, cognitive functions, and atypical depressive features in obese and depressed patients. It is expected that obese and depressed patients will show similar features in terms of biochemical parameters and cognitive functions, and atypical depressive features may be high in obese individuals. Materials and methods: The study included 56 obese individuals, 60 patients with major depressive disorder (MDD), and 53 healthy controls (HC). The questionnaires administered included socio-demographic data form, Hamilton Depression Rating Scale, Hamilton Anxiety Scale, Dutch Eating Behaviour Questionnaire, Structured Interview Guide for the Hamilton Depression Rating Scale-Seasonal Affective Disorder Version (SIGH-SAD). Cognitive functions were assessed with short computer version of Wisconsin Card Sorting Test (WCST), Berg’s WCST, Stroop Colour-Word Test-Victoria version. Serum ghrelin, leptin, and neuropeptide Y levels were measured. Results: The depression scores were found higher MDD group than obesity and HC groups (p<0.001) and anxiety scores similar in MDD and obesity groups (p=0.064). The groups had similar mean SIGH-SAD scores (p=0.989). There was no difference between groups in WCST scores (p>0.05). Differences were detected between the groups in the Stroop test. Leptin levels were higher (p<0.001), ghrelin (p=0.038) and neuropeptide Y (p<0.001) levels lower in obesity group compared to MDD and HC. Ghrelin levels negatively correlated with total number of incorrect responses in terms of cognitive functions in obese individuals (r=-0.259 p=0.049). Conclusion: In our study, it was determined that although depressive symptoms were high in obesity, there were no atypical depressive features, executive functions were similar between the groups, and neurochemical marker levels were not similar in obesity and depression. Our results do not support the relationship between obesity and atypical depression.

Pamukkale Medical JournalVol. 18(3)
Pamukkale University (TR)
Openalex Percentile: Top 83%
Regulation of Appetite and Obesity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.